跳至主要内容
临床试验/IRCT20240515061805N1
IRCT20240515061805N1招募中2 期

Comparison of dexmedetomidine versus propofol intravenous sedation for electrochemotherapy of breast cancer skin lesion: double-blinded clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Symptomatic metastatic skin lesions (like bleeding, exudation, smell or ulceration)
  • development of skin metastases, in which the symptoms mentioned can be expected
  • Patients who receive systemic treatment and have a good effect on their primary cancer, but their skin lesions do not respond to these treatments or are progressing
  • patients preferring electrochemistry
  • multiple skin lesions or a lesion larger than 1 cm
  • ASA group II, I, III
  • patients between 18 and 60 years old

排除标准

  • Pregnancy and breastfeeding
  • Allergy to any of the drugs used in the study
  • hypertension
  • impaired liver and kidney function
  • Hereditary heart diseases
  • ischemic heart disease,
  • using beta blockers and sedative drugs
  • refusing to sign an informed consent form

研究者

相似试验

Comparison of the Effectiveness of dexmedetomidine... | 临床试验